11.71
前日終値:
$11.40
開ける:
$11.4
24時間の取引高:
4.67M
Relative Volume:
0.99
時価総額:
$1.26B
収益:
$45.97M
当期純損益:
$-508.80M
株価収益率:
-2.1369
EPS:
-5.48
ネットキャッシュフロー:
$-382.65M
1週間 パフォーマンス:
+2.54%
1か月 パフォーマンス:
+1.91%
6か月 パフォーマンス:
+23.92%
1年 パフォーマンス:
-45.84%
Intellia Therapeutics Inc Stock (NTLA) Company Profile
名前
Intellia Therapeutics Inc
セクター
電話
857-285-6200
住所
40 ERIE STREET, CAMBRIDGE, MA
NTLA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
NTLA
Intellia Therapeutics Inc
|
11.71 | 1.22B | 45.97M | -508.80M | -382.65M | -5.48 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Intellia Therapeutics Inc Stock (NTLA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-21 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2025-03-05 | 開始されました | H.C. Wainwright | Buy |
2025-02-28 | ダウングレード | Goldman | Neutral → Sell |
2025-02-28 | ダウングレード | JP Morgan | Overweight → Neutral |
2025-01-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-02-23 | ダウングレード | Goldman | Buy → Neutral |
2024-02-15 | 開始されました | Wolfe Research | Peer Perform |
2023-04-13 | 開始されました | Canaccord Genuity | Buy |
2023-03-21 | 開始されました | Bernstein | Outperform |
2023-03-14 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2023-02-01 | 開始されました | Cantor Fitzgerald | Overweight |
2023-01-24 | アップグレード | Citigroup | Sell → Neutral |
2023-01-19 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
2022-10-11 | 開始されました | Morgan Stanley | Overweight |
2022-09-21 | 開始されました | JP Morgan | Overweight |
2022-09-01 | 開始されました | Citigroup | Sell |
2022-06-17 | 開始されました | BMO Capital Markets | Market Perform |
2022-06-16 | 開始されました | BofA Securities | Buy |
2022-04-28 | 開始されました | Credit Suisse | Outperform |
2022-02-18 | 開始されました | William Blair | Outperform |
2022-02-07 | アップグレード | Oppenheimer | Perform → Outperform |
2022-01-31 | 開始されました | Cowen | Outperform |
2022-01-07 | 開始されました | Piper Sandler | Overweight |
2021-10-05 | 開始されました | Guggenheim | Buy |
2021-09-24 | 開始されました | Stifel | Buy |
2021-06-28 | 繰り返されました | H.C. Wainwright | Buy |
2021-06-11 | 開始されました | H.C. Wainwright | Buy |
2021-05-07 | アップグレード | ROTH Capital | Neutral → Buy |
2021-05-04 | 開始されました | RBC Capital Mkts | Outperform |
2021-03-04 | 開始されました | JMP Securities | Mkt Outperform |
2020-12-22 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2020-10-27 | 開始されました | Truist | Buy |
2020-10-14 | 開始されました | Wells Fargo | Overweight |
2020-09-18 | 開始されました | Goldman | Buy |
2020-02-28 | アップグレード | Oppenheimer | Perform → Outperform |
2020-02-14 | ダウングレード | Wedbush | Outperform → Neutral |
2019-11-01 | アップグレード | Raymond James | Mkt Perform → Outperform |
2019-07-09 | 開始されました | Robert W. Baird | Outperform |
2019-06-10 | 開始されました | ROTH Capital | Neutral |
2019-05-03 | アップグレード | Wedbush | Neutral → Outperform |
2019-04-12 | 開始されました | Evercore ISI | Outperform |
2018-11-02 | ダウングレード | Wedbush | Outperform → Neutral |
2018-10-29 | 開始されました | Credit Suisse | Neutral |
2018-09-21 | 開始されました | Raymond James | Mkt Perform |
2018-05-15 | アップグレード | Chardan Capital Markets | Neutral → Buy |
2018-03-08 | 開始されました | JMP Securities | Mkt Outperform |
2017-11-01 | 繰り返されました | Jefferies | Buy |
2017-06-22 | 再開されました | Jefferies | Buy |
2017-03-28 | 開始されました | Chardan Capital Markets | Buy |
2016-08-05 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Intellia Therapeutics Inc (NTLA) 最新ニュース
Cathie Wood’s ARK ETF adjusts portfolio, sells Roku stock, buys CRISPR and Intellia - Investing.com
Panic Selling: Is Intellia Therapeutics Inc. benefiting from interest rate changesJuly 2025 Drop Watch & Verified High Yield Trade Plans - khodrobank.com
Signal strength of Intellia Therapeutics Inc. stock in tech scannersQuarterly Earnings Report & Safe Capital Growth Tips - Newser
Does Intellia Therapeutics Inc. stock have upside surprise potentialJuly 2025 Big Picture & Real-Time Buy Zone Alerts - khodrobank.com
Real time alert setup for Intellia Therapeutics Inc. performanceJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser
How to forecast Intellia Therapeutics Inc. trends using time series2025 Support & Resistance & High Yield Stock Recommendations - Newser
Intellia Therapeutics Inc. stock outlook for YEARPortfolio Growth Summary & Weekly Sector Rotation Insights - Newser
Leading vs lagging indicators on Intellia Therapeutics Inc. performanceWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
What the charts say about Intellia Therapeutics Inc. todayPortfolio Value Report & Stepwise Swing Trade Plans - Newser
Tools to assess Intellia Therapeutics Inc.’s risk profileQuarterly Trade Report & Expert Verified Stock Movement Alerts - Newser
Why Intellia Therapeutics Inc. is moving today2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Multi asset correlation models including Intellia Therapeutics Inc.Profit Target & Daily Oversold Stock Bounce Ideas - Newser
Merger Talk: Is Intellia Therapeutics Inc. benefiting from interest rate changesEarnings Performance Report & Stepwise Trade Signal Implementation - khodrobank.com
Is Intellia Therapeutics Inc. stock reversal real or fakeJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser
How hedge fund analytics apply to Intellia Therapeutics Inc. stockWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Will Intellia Therapeutics Inc. outperform tech stocksMarket Activity Report & Technical Buy Zone Confirmation - khodrobank.com
What’s next for Intellia Therapeutics Inc. stockMarket Sentiment Report & Real-Time Stock Price Movement Reports - khodrobank.com
Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus - TradingView
Gene Editing Market to Surpass USD 15.46 Billion by 2032, Fueled by Breakthroughs in CRISPR Technology and Precision Medicine – SNS Insider - GlobeNewswire Inc.
Intellia Therapeutics Inc. Stock Flags Risk Zone in Volatility Index getLinesFromResByArray error: size == 0 - thegnnews.com
Aug Levels: What’s next for Intellia Therapeutics Inc. stockInsider Selling & Short-Term Trading Opportunity Alerts - khodrobank.com
Is Intellia Therapeutics Inc. building a consolidation base2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Pattern recognition hints at Intellia Therapeutics Inc. upside2025 Market WrapUp & High Accuracy Swing Entry Alerts - Newser
Why is Intellia Therapeutics Inc. stock going upJuly 2025 Update & High Accuracy Trade Signal Alerts - khodrobank.com
Is Intellia Therapeutics Inc. stock good for income investorsPortfolio Performance Report & Consistent Profit Trade Alerts - خودرو بانک
Insider Buy: Can Intellia Therapeutics Inc. navigate macro headwindsWeekly Trade Recap & Weekly Top Performers Watchlists - khodrobank.com
Why big players are pouring millions in THIS biotech stock - TradingView
Key metrics from Intellia Therapeutics Inc.’s quarterly dataJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser
Intellia Therapeutics Inc. stock chart pattern explainedJuly 2025 Review & Weekly High Potential Stock Alerts - Newser
Applying sector rotation models to Intellia Therapeutics Inc.Trade Entry Report & Fast Entry High Yield Stock Tips - Newser
Intellia Therapeutics Inc. stock prediction for this week2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
Using Python tools to backtest Intellia Therapeutics Inc. strategiesJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Chart based analysis of Intellia Therapeutics Inc. trendsJuly 2025 Patterns & Safe Entry Momentum Tips - Newser
ARK Investment buys 560K shares of Intellia Therapeutics - MSN
Detecting support and resistance levels for Intellia Therapeutics Inc.Portfolio Risk Summary & Low Drawdown Trading Techniques - Newser
Is Intellia Therapeutics Inc. a candidate for recovery playJuly 2025 Institutional & Scalable Portfolio Growth Methods - Newser
Will Intellia Therapeutics Inc. bounce back from current support2025 Dividend Review & Risk Controlled Daily Trade Plans - Newser
Is Intellia Therapeutics Inc. trending in predictive chart modelsOil Prices & Free Technical Confirmation Trade Alerts - Newser
Cathie Wood Invests $4M in Intellia Therapeutics, Trims Stakes in Roku and DraftKings - AInvest
Intellia Therapeutics Inc (NTLA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):